5.625
price down icon1.83%   -0.105
after-market Dopo l'orario di chiusura: 5.63 0.005 +0.09%
loading
Precedente Chiudi:
$5.73
Aprire:
$5.75
Volume 24 ore:
1.96M
Relative Volume:
0.78
Capitalizzazione di mercato:
$2.08B
Reddito:
$9.47B
Utile/perdita netta:
$-178.00M
Rapporto P/E:
-11.72
EPS:
-0.48
Flusso di cassa netto:
$1.01B
1 W Prestazione:
-7.94%
1M Prestazione:
-0.62%
6M Prestazione:
-21.98%
1 anno Prestazione:
-19.76%
Intervallo 1D:
Value
$5.565
$5.77
Intervallo di 1 settimana:
Value
$5.565
$6.095
Portata 52W:
Value
$4.25
$8.685

Bausch Health Companies Inc Stock (BHC) Company Profile

Name
Nome
Bausch Health Companies Inc
Name
Telefono
514-744-6792
Name
Indirizzo
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Name
Dipendente
20,300
Name
Cinguettio
Name
Prossima data di guadagno
2024-10-30
Name
Ultimi documenti SEC
Name
BHC's Discussions on Twitter

Compare BHC vs TAK, ZTS, HLN, TEVA, UTHR

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
BHC
Bausch Health Companies Inc
5.625 2.12B 9.47B -178.00M 1.01B -0.48
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
18.22 57.12B 29.85B 776.90M 4.35B 0.2408
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
125.98 53.16B 9.47B 2.67B 2.28B 6.0218
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.48 47.25B 14.54B 2.22B 2.58B 0.4879
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
32.88 37.59B 17.41B 1.43B 1.00B 1.2182
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
490.21 21.85B 3.13B 1.27B 1.12B 26.39

Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-12-09 Iniziato Barclays Equal Weight
2024-08-02 Downgrade Piper Sandler Neutral → Underweight
2024-07-10 Iniziato Raymond James Mkt Perform
2023-09-20 Aggiornamento Jefferies Hold → Buy
2023-06-16 Downgrade TD Cowen Outperform → Market Perform
2022-07-29 Downgrade RBC Capital Mkts Outperform → Sector Perform
2022-07-29 Downgrade Truist Buy → Hold
2022-07-28 Downgrade JP Morgan Overweight → Neutral
2022-06-13 Ripresa JP Morgan Overweight
2021-03-24 Downgrade BofA Securities Neutral → Underperform
2021-02-17 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2021-01-22 Downgrade Piper Sandler Overweight → Neutral
2020-09-17 Aggiornamento BofA Securities Underperform → Neutral
2020-08-24 Reiterato H.C. Wainwright Buy
2020-06-17 Reiterato H.C. Wainwright Buy
2020-04-24 Iniziato Citigroup Buy
2020-04-02 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-01-29 Downgrade Wolfe Research Outperform → Peer Perform
2020-01-22 Aggiornamento Wells Fargo Underweight → Equal Weight
2019-12-12 Aggiornamento JP Morgan Neutral → Overweight
2019-12-02 Iniziato Goldman Neutral
2019-10-25 Iniziato Cowen Outperform
2019-09-12 Iniziato Guggenheim Buy
2019-08-15 Aggiornamento TD Securities Hold → Buy
2019-07-19 Iniziato Wolfe Research Outperform
2019-06-11 Ripresa Barclays Overweight
2019-05-13 Aggiornamento JP Morgan Underweight → Neutral
2019-03-20 Iniziato SunTrust Buy
2019-01-02 Aggiornamento Piper Jaffray Neutral → Overweight
2018-11-05 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2018-09-13 Aggiornamento Piper Jaffray Underweight → Neutral
Mostra tutto

Bausch Health Companies Inc Borsa (BHC) Ultime notizie

pulisher
Mar 03, 2026

Bausch Health (NYSE: BHC) CFO reports tax-withholding share disposition - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Bausch Health (BHC) EVP Carson trades shares, settles equity awards - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Tax withholding and cash PSU settlement for Bausch Health (BHC) CEO - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Seana Carson reports sales of 8,388 and 6,856 shares — BHC (NYSE: BHC) - Stock Titan

Mar 03, 2026
pulisher
Mar 02, 2026

Bausch Health updates executive compensation agreements to cash settlement for 2023 PSUs - Investing.com Canada

Mar 02, 2026
pulisher
Mar 02, 2026

Bausch Health updates executive compensation agreements to cash settlement for 2023 PSUs By Investing.com - Investing.com Australia

Mar 02, 2026
pulisher
Mar 02, 2026

Bausch Health (NYSE: BHC) converts 2023 executive PSUs into cash-settled awards - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Bausch Health (NYSE:BHC) Stability Story Amid Canada Pharma Shifts Nyse Composite Today - Kalkine Media

Mar 02, 2026
pulisher
Mar 02, 2026

Proposed insider sale at BHC (NYSE: BHC) — 6,856 common shares - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Bausch Health Cos Inc. (NYSE:BHC) Receives Average Rating of "Reduce" from Analysts - MarketBeat

Mar 02, 2026
pulisher
Mar 02, 2026

Bausch Health Marks Arestin Milestone And Highlights Niche Dental Opportunity - Sahm

Mar 02, 2026
pulisher
Feb 28, 2026

Is Bausch Health (BHC) Pricing Reflect Its Sharp Multi‑Year Share Price Declines? - Sahm

Feb 28, 2026
pulisher
Feb 28, 2026

Assessing Bausch Health (BHC) Valuation After Years Of Weak Returns And Ongoing Debt Reduction Efforts - Sahm

Feb 28, 2026
pulisher
Feb 27, 2026

Bausch Health (BHC) SVP Steven Lee receives 45,868 restricted share units - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

Bausch Health (NYSE: BHC) EVP receives RSU grant, tax shares withheld - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

Insider moves at Bausch Health (BHC): RSU grant, tax shares, open-market sale - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

Bausch Health (NYSE: BHC) CFO awarded RSUs; shares withheld for tax obligations - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

Should Bausch Health’s Profit Return and 2026 Outlook Shift the Investment Case for BHC? - Yahoo Finance

Feb 27, 2026
pulisher
Feb 25, 2026

BHC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 25, 2026
pulisher
Feb 25, 2026

Bausch Health Cos (NYSE:BHC) Price Target Cut to $7.00 by Analysts at Barclays - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Signal Recap: Is now the right time to enter SAIAQuarterly Market Summary & Daily Entry Point Trade Alerts - baoquankhu1.vn

Feb 25, 2026
pulisher
Feb 25, 2026

EV Market: Is Bausch Health Companies Inc backed by strong institutional buyingMarket Volume Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn

Feb 25, 2026
pulisher
Feb 25, 2026

Bausch Health (NYSE: BHC) CEO granted 815K RSUs, 116K shares withheld for tax - Stock Titan

Feb 25, 2026
pulisher
Feb 24, 2026

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a 31.39% Potential Upside for Savvy Investors - DirectorsTalk Interviews

Feb 24, 2026
pulisher
Feb 24, 2026

Trading Recap: Is Bausch Health Companies Inc stock a value trapJuly 2025 Gainers & Free Community Consensus Stock Picks - baoquankhu1.vn

Feb 24, 2026
pulisher
Feb 23, 2026

Separation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) Outlook - Insider Monkey

Feb 23, 2026
pulisher
Feb 23, 2026

Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada - PR Newswire

Feb 23, 2026
pulisher
Feb 23, 2026

New anti-aging laser lets Canadian clinics target wrinkles, spots, pores - Stock Titan

Feb 23, 2026
pulisher
Feb 22, 2026

Bausch Health Weighs China Aesthetics Push Against ARESTIN Milestone And Debt - Yahoo Finance

Feb 22, 2026
pulisher
Feb 21, 2026

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch Health Companies (BHC), Fennec Pharmaceuticals (FENC) and InfuSystem Holdings (INFU) - The Globe and Mail

Feb 21, 2026
pulisher
Feb 20, 2026

Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now? - sharewise.com

Feb 20, 2026
pulisher
Feb 20, 2026

Analysts Offer Insights on Healthcare Companies: KalVista Pharmaceuticals (KALV), Bausch Health Companies (BHC) and Insulet (PODD) - The Globe and Mail

Feb 20, 2026
pulisher
Feb 20, 2026

Bausch Health Companies Inc. (NYSE:BHC) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 20, 2026
pulisher
Feb 20, 2026

Can Bausch Health Companies Inc expand into new markets2025 Trade Ideas & Weekly Sector Rotation Insights - baoquankhu1.vn

Feb 20, 2026
pulisher
Feb 20, 2026

Bausch Health revenue by segment 2021-2024 - Statista

Feb 20, 2026
pulisher
Feb 19, 2026

Bausch + Lomb Q4 Earnings Review: Still A Buy, With Some Caveats (NYSE:BLCO) - Seeking Alpha

Feb 19, 2026
pulisher
Feb 19, 2026

BHC Stock Down on Q4 Earnings Miss, Salix Drives Revenue Growth - Finviz

Feb 19, 2026
pulisher
Feb 19, 2026

Bausch Health Cos (NYSE:BHC) Shares Gap DownTime to Sell? - MarketBeat

Feb 19, 2026
pulisher
Feb 19, 2026

How Bausch Health’s Turnaround Progressed In Q4 2025 (NYSE:BHC) - Seeking Alpha

Feb 19, 2026
pulisher
Feb 19, 2026

Bausch Health Companies Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Feb 19, 2026
pulisher
Feb 19, 2026

Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres - Yahoo Finance

Feb 19, 2026
pulisher
Feb 19, 2026

Will Bausch Health Companies Inc announce a stock splitQuarterly Market Summary & Risk Controlled Swing Alerts - baoquankhu1.vn

Feb 19, 2026
pulisher
Feb 19, 2026

Bausch Health Companies Inc (BHC) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada

Feb 19, 2026
pulisher
Feb 19, 2026

Bausch Health expects 3% revenue growth in 2026 while strengthening balance sheet and expanding in China - MSN

Feb 19, 2026
pulisher
Feb 19, 2026

A Look At Bausch Health Companies (BHC) Valuation After Mixed Quarterly Results And China Expansion - Sahm

Feb 19, 2026
pulisher
Feb 19, 2026

Bausch Health (BHC) Q4 2025 Earnings Transcript - The Globe and Mail

Feb 19, 2026
pulisher
Feb 18, 2026

Bausch Health Cos Q4 Earnings Call Highlights - Yahoo Finance

Feb 18, 2026
pulisher
Feb 18, 2026

Bausch Health (BHC) Q4 Earnings Lag Estimates - Yahoo Finance

Feb 18, 2026
pulisher
Feb 18, 2026

Here's What Key Metrics Tell Us About Bausch (BHC) Q4 Earnings - Nasdaq

Feb 18, 2026
pulisher
Feb 18, 2026

Bausch: Q4 Earnings Snapshot - kens5.com

Feb 18, 2026
pulisher
Feb 18, 2026

Bausch Health Cos (NYSE:BHC) Releases Earnings Results, Misses Expectations By $0.14 EPS - MarketBeat

Feb 18, 2026

Bausch Health Companies Inc Azioni (BHC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
drug_manufacturers_specialty_generic RDY
$14.32
price up icon 0.49%
$24.73
price down icon 0.60%
drug_manufacturers_specialty_generic RGC
$25.25
price up icon 4.46%
$132.25
price up icon 0.53%
$14.86
price down icon 0.34%
$487.88
price down icon 2.11%
Capitalizzazione:     |  Volume (24 ore):